Functional dissection of the human Bcl2 protein: sequence requirements for inhibition of apoptosis
- PMID: 8622689
- PMCID: PMC231068
- DOI: 10.1128/MCB.16.3.877
Functional dissection of the human Bcl2 protein: sequence requirements for inhibition of apoptosis
Abstract
Overexpression of the cytoplasmic oncoprotein Bcl2 blocks programmed cell death (apoptosis) in many cellular systems. To map the sequences in Bcl2 that are necessary for its activity, we created a library of deletion-scanning mutants of this 239-amino-acid protein and tested their abilities to block staurosporine-induced fibroblast apoptosis, using a novel transient-transfection assay. Phenotypes of informative mutants were then confirmed by assaying for inhibition of steroid-induced apoptosis in stably transfected T-lymphoid cells. In accordance with earlier results, we found that Bcl2 activity was only partially reduced after deletion of the hydrophobic tail that normally anchors it in cytoplasmic membranes. Essential sequences were found in the remainder of the protein and appeared to be organized in at least two discrete functional domains. The larger, more C-terminal region (within residues 90 to 203) encompassed, but extended beyond, two oligopeptide motifs called BH1 and BH2, which are known to mediate dimerization of Bcl2 and related proteins. The second, more N-terminal regions (within residues 6 to 31) was not required for protein dimerization in vivo, but its deletion imparted a dominant negative phenotype, yielding mutants that promoted rather than inhibited apoptotic death. Residues 30 to 91 were not absolutely required for function; by deleting most of this region along with the hydrophobic tail, we derived a 155-residue mini-Bcl2 that retains significant ability to inhibit apoptosis.
Similar articles
-
Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway.Hum Mol Genet. 2001 Oct 1;10(21):2329-39. doi: 10.1093/hmg/10.21.2329. Hum Mol Genet. 2001. PMID: 11689480
-
Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.J Biol Chem. 1996 Mar 29;271(13):7440-4. doi: 10.1074/jbc.271.13.7440. J Biol Chem. 1996. PMID: 8631771
-
Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.Oncogene. 1998 Jun 18;16(24):3105-14. doi: 10.1038/sj.onc.1201851. Oncogene. 1998. PMID: 9671389
-
Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.Adv Exp Med Biol. 1996;406:99-112. Adv Exp Med Biol. 1996. PMID: 8910675 Review.
-
Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.J Natl Cancer Inst Monogr. 2001;(28):30-7. doi: 10.1093/oxfordjournals.jncimonographs.a024254. J Natl Cancer Inst Monogr. 2001. PMID: 11158204 Review.
Cited by
-
The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.EMBO J. 1998 Feb 16;17(4):1029-39. doi: 10.1093/emboj/17.4.1029. EMBO J. 1998. PMID: 9463381 Free PMC article.
-
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.Cancer Cell. 2015 Jun 8;27(6):852-63. doi: 10.1016/j.ccell.2015.04.010. Epub 2015 May 21. Cancer Cell. 2015. PMID: 26004684 Free PMC article.
-
Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.J Virol. 2000 Jun;74(11):5024-31. doi: 10.1128/jvi.74.11.5024-5031.2000. J Virol. 2000. PMID: 10799576 Free PMC article.
-
The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L).Mol Cell Biol. 1999 Oct;19(10):6673-81. doi: 10.1128/MCB.19.10.6673. Mol Cell Biol. 1999. PMID: 10490606 Free PMC article.
-
Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.Cell Death Differ. 2012 Feb;19(2):295-309. doi: 10.1038/cdd.2011.97. Epub 2011 Aug 5. Cell Death Differ. 2012. PMID: 21818117 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources